Contents

back to top


2017.12.01

Vol.45, No.3, Nov. 2017
Partnership for NTDs drug discovery originated in Japan /
The past, present and future of bioethics and research ethics (Part IV)

Vol.45, No.2, Aug. 2017
5th World Centenarian Initiative International Symposium on Stroke /
The past, present and future of bioethics and research ethics (Part III)

Vol.45, No.1, Apr. 2017
The past, present and future of bioethics and research ethics (Part II) /
2nd Taiwan-Japan Academic Research Organization Workshop / ASIA ARO Network Workshop

Vol.44, No.4, Feb. 2017
Overcoming neurodegenerative diseases by innovative therapeutic developments /
4th World Centenarian Initiative@2nd Medical Technological Innovation Symposium in Hirosaki /
Toward the global standardization of molecular imaging biomarkers

Vol.44, No.3, Dec. 2016
Paradigms shift of drug discovery, development and lifetime management /
Taiwan-Japan Academic Research Organization Workshop 2015 /
3rd World Centenarian Initiative International Symposium on Amyotrophic Lateral Sclerosis

Vol.44, No.2, Jun. 2016
The 14th Setouchi International Conference on Clinical Trials /
The past, present and future of bioethics and research ethics (Part I)

Vol.44, No.1, Apr. 2016
2nd World Centenarian Initiative International Symposium on Alzheimer's Diseases Prevention Strategy /
The 30th Japan Association for International Health Congress 2015 Trend in global health and infectious diseases

Vol.43, No.2, Jan. 2016
Rare and Intractable Diseases Translational Research Conference 2014 Toward the New Horizon of Rare Disease /
Consolidated strategic meeting for cancer research and management in disruptive innovation era

Vol.43, Suppl XXXV 2015
Public Debriefing Session 2014

Vol.43, No.1, Aug. 2015
The 33rd Aso-Kujyu Conference on Clinical Pharmacology /
Consolidated Strategic Meeting on Development of Next-generation Cancer Molecular-targeted Therapy /
The 2nd Translational Research Center Workshop /
The challenge of developing new treatments for NTDs originating from Japan

Vol.43, Suppl XXXIV 2015
Moving beyond the Comfort Zone

Vol.42, Suppl XXXIII 2014
Public Debriefing Session 2013

Vol.42, No.2, Oct. 2014
The 12th Setouchi International Conference on Clinical Trials /
The 32nd Aso-Kujyu Conference on Clinical Pharmacology /
Medical Innovation Management and the trend of data standardization

Vol.42, No.1, Jul. 2014
Overcoming neuronal system refractory diseases: The current situation and future prospects for the development of innovative therapies for spinal cord injury / Translational Research Center Workshop

Vol.42, Suppl XXXII 2014
Next Steps and Actions as one of the Leading Countries

Vol.41, No.4, Feb. 2014
Reformation of clinical research and medical innovation policies in Japan: Challenges and opportunities /
Reflecting on the credibility of investigator-initiated clinical trials /
The regulations and credibility of investigator-initiated clinical trials in the United States and Europe

Vol.41, No.3, Jan. 2014
The 3rd International Symposium of Early Stage Clinical Trial /
Urgent special topic@Opinions on the concept paper of integrating epidemiological and clinical guidelines

Vol.41, No.2, Oct. 2013
The 11st Setouchi International Conference on Clinical Trials /
Expert Conference on the Revision of the Declaration of Helsinki in Tokyo /
Neurosurgical treatment of psychiatric disorders

Vol.41, No.1, Jul. 2013
Public Debriefing Session 2012

Vol.40, No.2, Mar. 2013
Dawning of the gSunshine Acth: Towards a new phase of conflict of interest management /
The 2nd International Symposium of Early Stage Clinical Trial /
The 31st Aso-Kuju Conference on Clinical Pharmacology

Vol.40, No.1, Oct. 2012
New trend of clinical trial and clinical research /
The 10th Setouchi International Conference on Clinical Trials

Vol.40, Suppl XXXI 2012
Public Debriefing Session 2011

Vol.40, Suppl XXX 2012
Innovative Strategies for Enhancing Regional Drug Development as a Global Drug Development

Vol.39, No.3, Mar. 2012
The 30th Aso-Kuju Conference on Clinical Pharmacology / First-in-Human Trial Seminar & Workshop

Vol.39, No.2, Oct. 2011
Public Debriefing Session 2010 / International symposium of early stage clinical trial in Beppu

Vol.39, No.1, Jun. 2011
The status and perspectives of compensation for research-related injuries

Vol.39, Suppl XXIX 2011
Innovative Strategies for Future Objectives

Vol.38, No. 4, Mar. 2011
The international conference in Matsuyama for promoting global clinical new drug developments /
Consensus meeting for adipose tissue derived stem cell therapy

Vol.38, No. 3, Oct. 2010
The 8th Translational Research Educational Program / Public Debriefing Session 2009

Vol.38, No. 2, Sep. 2010
The use of Bayesian statistics in clinical trials

Vol.38, No. 1, Jun. 2010
ICH-S7B, E14: The notifications in Japan and their impact on new drug development

Vol.37, Suppl XXVIII 2010
Significance of Asian Studies in Simultaneous Global Clinical Trials

Vol.37, No.2, Feb. 2010
The international meeting for promotion of global clinical development in Tokyo
What is the true endpoint of global clinical trials and how do we manage?

Vol.37, No.1, Oct. 2009
10th annual meeting of the Japan Society of Clinical Pharmacological Studies /
The 27th Aso-Kujyu Conference on Clinical Pharmacology

Vol.37, Suppl XXVII 2009
Learning from Experience and New Challenges for the Future
Vol.36, Suppl XXVI 2009
Clinical science : Principles and practice|Science, law and humanity|

Vol.36, No.3, Apr. 2009
Microdosing clinical trials of biologics

Vol.36, No.2, Dec. 2008
Drug development and Medical Research Act in the Netherlands

Vol.36, No.1, Aug. 2008
The symposium on Deep Brain Stimulation (DBS) therapy for Psychiatric Disorders
At the 47th meeting of the Japan Society for Stereotactic and Functional Neurosurgery

Vol.35, No.3, Jun. 2008
J-CLIPNET - Bases for early phase global clinical development

Vol.35, No.2, Dec. 2007
The international meeting for promotion of global clinical development in Beppu

Vol.35, No.1, Sep. 2007
A handbook for IRB members

Vol.35, Suppl XXV 2007
Japan's Critical Path Opportunities

Vol.34, No.3, May 2007
Safety information: reporting, dissemination, and analysis

Vol.34, No.2, Apr. 2007
What is the future of obstetric medicine?

Vol.34, No.1, Feb. 2007
CIOMS Guidelines for Biomedical Research

Vol.34, Suppl XXIV 2006
What is the TGN 1412 case ?

Vol.33, No.3, Oct. 2006
Basis of translational research: Academia-oriented clinical trials and new drug and medical technology development

Vol.33, Suppl XXIII 2006
Development, Evaluation and Approval of New Drugs

Vol.33, No.2, Apr. 2006
Position and role of the Asian and Oceanic regions in drug development

Vol.33, No.1, Dec. 2005
ARO and IRB: Business-academia collaboration

Vol.32, No.2E3, Sep. 2005
Risk management of pharmaceuticals|product management and project management|

Vol.32, Suppl XXII 2005
Global Development Strategies of New Drugs

Vol.32, No.1, Apr. 2005
Clinical trial registration and the issue of "Mixed health insurance"

Vol.32, Suppl XXI 2004
Scientific and ethical evaluation of regenerative medicine
Focus on bone marrow and fetal stem cell clinical research

Vol.31, No.3, Sep. 2004
Actual status of the new drug approval review system

Vol.31, Suppl XX 2004
Forefront of New Drug Development Strategies

Vol.31, No.2, Apr. 2004
The regulatory situations of clinical trials in the US, Europe and Asia

Vol.31, No.1, Dec. 2003
The changing situation of clinical trials and support systems: Actual problems and how to solve them

Vol.30, No.23, Sep. 2003
Clinical research in the "Bio-Genome Century" and the revised Pharmaceutical Affairs Law

Vol.30, Suppl XIX 2003
Simultaneous, Worldwide Development Strategies

Vol.30 Suppl XVIII, 2003
LQۂ̐ffw|iƗLQۂƂ̈ʊ֌W̎|

Vol.30, No.1, Oct. 2002
Quality assurance of investigator-oriented clinical research in Japan
|Current status and efforts towards future development|

Vol.29, No.23, May 2002
Knowledge management and knowledge sharing

Vol. 29, Suppl XVII, 2002
Bridging Strategies and Pharmacogenomics

Vol. 29, No. 1, Nov. 2001
Drug safety-current status and future perspectives

Vol. 29, Suppl XVI, 2001
Clinical Evaluation of OTC Drugs and Traditional Drugs

Vol. 28, Suppl XV, 2001
Bridging Strategies

Vol. 28, No. 3, Jun 2001
The 2000 revision to the Declaration of Helsinki and ethics in this era of globalization

Vol. 28, No. 2, Jan. 2001
Support systems for clinical trials under the new GCP

Vol. 28, No. 1, Oct. 2000
External quality assurance in clinical trials

Vol. 27, Suppl XIV, 2000
World wide view on development and evaluation of switched and direct OTC

Vol. 27, No. 3, Apr. 2000
Information disclosure on clinical trials and international public health

Vol. 27, No. 2, Dec. 1999
Present Status of Clinical Trials and Supporting Systems in Three Regions (Japan, the US and Europe)

Vol. 27, No. 1, Sep. 1999
Application of Statistical Principles for Clinical Trials

Vol. 26, Suppl XIII 1999
Evidence of Off-Label Use of Drug

Vol.26, No.3, Feb. 1999
 
Vol.26, No.2, Nov. 1998
 
Vol.26, No.1, Jul. 1998
 
Vol.25, No.23, Apr. 1998
 
Vol.25, No.1, Sep. 1997
 


back to top
back to Rinsho Hyoka (Clinical Evaluation)